Literature DB >> 32669923

Management of dyspnea in palliative care.

A M Crombeen1, E J Lilly1.   

Abstract

Dyspnea is a symptom commonly experienced by cancer patients that causes significant suffering, worsens throughout a patient's disease trajectory, and can be more difficult to manage than other symptoms. Assessment of dyspnea is best accomplished by a subjective description; physiologic measures are only weakly correlated with the patient's experience. It is important to consider a wide range of possible malignant and nonmalignant causes of dyspnea in cancer patients and to correct underlying causes where possible. For patients with refractory dyspnea, opioids are a safe and effective treatment. Benzodiazepines can be considered, but the evidence for their use is weak. Supplemental oxygen is beneficial if patients are hypoxemic, or if they have concurrent chronic obstructive pulmonary disease. Nonpharmacologic strategies such as fan therapy, exercise programs, and pulmonary rehabilitation can also be beneficial. One important diagnosis to consider in all cancer patients is venous thromboembolism. Prompt evaluation and treatment are vital to improving symptoms and outcomes for patients. Although dyspnea is common and potentially debilitating in cancer patients, it can be effectively managed with a structured approach to rule out reversible causes while concurrently treating the patient using appropriate therapeutic strategies. 2020 Multimed Inc.

Entities:  

Keywords:  Dyspnea; opioids; supplemental oxygen; venous thromboembolism

Mesh:

Year:  2020        PMID: 32669923      PMCID: PMC7339837          DOI: 10.3747/co.27.6413

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  24 in total

1.  Systematic lung scans reveal a high frequency of silent pulmonary embolism in patients with proximal deep venous thrombosis.

Authors:  M Meignan; J Rosso; H Gauthier; F Brunengo; S Claudel; L Sagnard; P d'Azemar; G Simonneau; B Charbonnier
Journal:  Arch Intern Med       Date:  2000-01-24

2.  Deep vein thrombosis and pulmonary embolism. An autopsy study with multiple regression analysis of possible risk factors.

Authors:  O Havig
Journal:  Acta Chir Scand Suppl       Date:  1977

Review 3.  Managing breathlessness: a palliative care approach.

Authors:  Chloe Chin; Sara Booth
Journal:  Postgrad Med J       Date:  2016-04-06       Impact factor: 2.401

Review 4.  Dyspnea review for the palliative care professional: treatment goals and therapeutic options.

Authors:  Arif H Kamal; Jennifer M Maguire; Jane L Wheeler; David C Currow; Amy P Abernethy
Journal:  J Palliat Med       Date:  2012-01       Impact factor: 2.947

5.  To What Extent Do the NRS and CRQ Capture Change in Patients' Experience of Breathlessness in Advanced Disease? Findings From a Mixed-Methods Double-Blind Randomized Feasibility Trial.

Authors:  Natasha Lovell; Simon Noah Etkind; Sabrina Bajwah; Matthew Maddocks; Irene Julie Higginson
Journal:  J Pain Symptom Manage       Date:  2019-06-13       Impact factor: 3.612

6.  Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial.

Authors:  Amy P Abernethy; Christine F McDonald; Peter A Frith; Katherine Clark; James E Herndon; Jennifer Marcello; Iven H Young; Janet Bull; Andrew Wilcock; Sara Booth; Jane L Wheeler; James A Tulsky; Alan J Crockett; David C Currow
Journal:  Lancet       Date:  2010-09-04       Impact factor: 79.321

7.  Update from the clinic: what's new in the diagnosis of cancer-associated thrombosis?

Authors:  Erica A Peterson; Agnes Y Y Lee
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

8.  Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy.

Authors:  A A Khorana; C W Francis; E Culakova; N M Kuderer; G H Lyman
Journal:  J Thromb Haemost       Date:  2007-03       Impact factor: 5.824

Review 9.  Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults.

Authors:  Steffen T Simon; Irene J Higginson; Sara Booth; Richard Harding; Vera Weingärtner; Claudia Bausewein
Journal:  Cochrane Database Syst Rev       Date:  2016-10-20

Review 10.  Thromboembolic disease and breathlessness.

Authors:  Simon Noble
Journal:  Curr Opin Support Palliat Care       Date:  2016-09       Impact factor: 2.302

View more
  1 in total

Review 1.  Interventions for palliative symptom control in COVID-19 patients.

Authors:  Marike Andreas; Vanessa Piechotta; Nicole Skoetz; Kathrin Grummich; Marie Becker; Lisa Joos; Gerhild Becker; Winfried Meissner; Christopher Boehlke
Journal:  Cochrane Database Syst Rev       Date:  2021-08-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.